Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vasilios G. Athyros, Niki Katsiki & Asterios Karagiannis. (2016) Off target effects of statins shape total mortality?. Journal of Drug Assessment 5:1, pages 4-5.
Read now
Read now
Konstantinos Tziomalos, Gerasimos E Krassas & Themistoklis Tzotzas. (2009) The use of sibutramine in the management of obesity and related disorders: An update. Vascular Health and Risk Management 5, pages 441-452.
Read now
Read now
Vasilios G Athyros, Konstantinos Tziomalos, Dimitri P Mikhailidis, Efstathios D Pagourelias, Anna I Kakafika, Athanasios Skaperdas, Apostolos Hatzitolios & Asterios Karagiannis. (2007) Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opinion on Pharmacotherapy 8:14, pages 2267-2277.
Read now
Read now
Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, Anna I Kakafika, Konstantinos Tziomalos, Evangelos N Liberopoulos, Matilda Florentin & Moses Elisaf. (2007) The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opinion on Therapeutic Targets 11:2, pages 191-205.
Read now
Read now
Evagelos N. Liberopoulos, Stella S. Daskalopoulou, Dimitri P. Mikhailidis, Anthony S. Wierzbicki & Moses S. Elisaf. (2005) A review of the lipid-related effects of fluvastatin. Current Medical Research and Opinion 21:2, pages 231-243.
Read now
Read now
Articles from other publishers (33)
Somnath GhoshDr.Dr., Apurba Bikash PramanikDr.Dr., Shampa MaityDr.Dr., Pulakesh SinhaDrDrDebarshi JanaDr.Dr.. (2020) A STUDY OF SERUM URIC ACID LEVELAND RISK FOR ACUTE ISCHEMIC NONEMBOLIC STROKE IN ELDERLY SUBJECTS. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 1-3.
Crossref
Crossref
Manoj Karki, Nabin Rokaya, Prabin Khatri, Aakash Shahi & Alok Sah. (2019) Study of Serum Uric Acid Level in Acute Coronary Syndrome. Trends Journal of Sciences Research 4:1, pages 21-28.
Crossref
Crossref
Kalliopi Pafili, Manfredi Rizzo & Nikolaos Papanas. (2018) New antihyperglycaemic agents and cardiovascular disease. Current Opinion in Cardiology 33:4, pages 444-454.
Crossref
Crossref
Stella S. Daskalopoulou & Dimitri P. Mikhailidis. 2018. Vascular Surgery. Vascular Surgery
189
200
.
Mohsen Hoseinian, Durdi Qujeq & Alijan Ahmadiahangar. (2017) Evaluation of Serum Uric Acid, Glucose and Nitrite-Nitrate Levels in Ischemic Stroke Patients. Journal of Clinical and Basic Research 1:4, pages 9-12.
Crossref
Crossref
Krishan Oberoi, Ashwani Kumar Sharma, Sushant Garg, Rajiv Sharma, Bhupinder Singh, Anbarasu K R, Sandeep Kaur & Sunil Kumar. (2017) TO STUDY SERUM URIC ACID AS A RISK FACTOR IN ACUTE ISCHAEMIC STROKE. Journal of Evolution of Medical and Dental Sciences 6:08, pages 647-652.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Devaki R. Nair. (2014) The effects of antiepileptic drugs on vascular risk factors: A narrative review. Seizure 23:9, pages 677-684.
Crossref
Crossref
Y.- S. Bao, X.- B. Jia, Y. Ji, J. Yang, S.- L. Zhao & S.- P. Na. (2014) High prevalence and risk factors for kidney dysfunction in patients with atherosclerotic cardio-cerebrovascular disease. QJM 107:6, pages 443-449.
Crossref
Crossref
Arvind Charan Mangal, Rishi T Guria & Manish Kumar Singh. (2013) SERUM URIC ACID LEVEL IN ACUTE ISCHAEMIC STROKE. Journal of Evolution of Medical and Dental sciences 2:36, pages 6915-6926.
Crossref
Crossref
Yu-Shi Bao, Li-Ting Song, Di Zhong, A-Xia Song, Xi-Bei Jia, Rui-Chan Liu, Ru-Juan Xie & Shi-Ping Na. (2013) Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke. European Journal of Clinical Investigation 43:8, pages 829-835.
Crossref
Crossref
Niki Katsiki, Asterios Karagiannis, Vasilios G. Athyros & Dimitri P. Mikhailidis. (2013) Hyperuricaemia. Journal of Cardiovascular Medicine 14:6, pages 397-402.
Crossref
Crossref
K. Papatheodorou, N. Papanas, D. Papazoglou, T. Gioka, C. Antonoglou, D. Glaros & E. Maltezos. (2012) Monocyte Chemoattractant Protein 1 Is Correlated With Glycemic Control and Peripheral Arterial Disease in Type 2 Diabetic Patients With Metabolic Syndrome. Angiology 64:3, pages 223-229.
Crossref
Crossref
N. PapanasN. Katsiki, K. Papatheodorou, M. Demetriou, D. Papazoglou, T. Gioka & E. Maltezos. (2011) Peripheral Neuropathy is Associated With Increased Serum Levels of Uric Acid in Type 2 Diabetes Mellitus. Angiology 62:4, pages 291-295.
Crossref
Crossref
N. Papanas, M. Demetriou, N. Katsiki, K. Papatheodorou, D. Papazoglou, T. Gioka, S. Kotsiou, E. Maltezos & D. P. Mikhailidis. (2011) Increased Serum Levels of Uric Acid Are Associated with Sudomotor Dysfunction in Subjects with Type 2 Diabetes Mellitus. Experimental Diabetes Research 2011, pages 1-5.
Crossref
Crossref
Lachy McLean & Michael A. Becker. 2011. Rheumatology. Rheumatology
1841
1857.e3
.
Christos Liapis. 2010. Rutherford's Vascular Surgery. Rutherford's Vascular Surgery
394
408
.
Stella S. Daskalopoulou & Dimitri P. Mikhailidis. 2011. Vascular Surgery. Vascular Surgery
165
172
.
Apostolos I. Hatzitolios, Triandafillos P. Didangelos, Anestis T. Zantidis, Konstantinos Tziomalos, George A. Giannakoulas & Dimitrios T. Karamitsos. (2009) Diabetes mellitus and cerebrovascular disease: which are the actual data?. Journal of Diabetes and its Complications 23:4, pages 283-296.
Crossref
Crossref
Robert Dons & Frank Wians. 2009. Endocrine and Metabolic Disorders. Endocrine and Metabolic Disorders
195
241
.
Efstathios D. Pagourelias, Charalambos Koumaras, Anna I. Kakafika, Konstantinos TziomalosParaskevi G. Zorou, Vasilios G. Athyros & Asterios Karagiannis. (2008) Cardiorenal Anemia Syndrome: Do Erythropoietin and Iron Therapy Have a Place in the Treatment of Heart Failure?. Angiology 60:1, pages 74-81.
Crossref
Crossref
Asterios Karagiannis, Dimitri P. Mikhailidis, Konstantinos Tziomalos, Maria Sileli, Savvas Savvatianos, Anna Kakafika, Thomas Gossios, Napoleon Krikis, Irene Moschou, Michael Xochellis & Vassilios G. Athyros. (2007) Serum Uric Acid as an Independent Predictor of Early Death After Acute Stroke. Circulation Journal 71:7, pages 1120-1127.
Crossref
Crossref
Stella S. Daskalopoulou, Marios E. Daskalopoulos, Christos D. Liapis & Dimitri P. Mikhailidis. 2007. Vascular Surgery. Vascular Surgery
111
116
.
Sofia G. Tsouli, Evangelos N. Liberopoulos, Dimitri P. Mikhailidis, Vasilios G. Athyros & Moses S. Elisaf. (2006) Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 55:10, pages 1293-1301.
Crossref
Crossref
Mohamad E. Alnaeb, Nasser Alobaid, Alexander M. Seifalian, Dimitri P. Mikhailidis & George Hamilton. (2006) Statins and Peripheral Arterial Disease: Potential Mechanisms and Clinical Benefits. Annals of Vascular Surgery 20:5, pages 696-705.
Crossref
Crossref
H J Milionis, E N Liberopoulos, A Achimastos, M S Elisaf & D P Mikhailidis. (2006) Statins: another class of antihypertensive agents?. Journal of Human Hypertension 20:5, pages 320-335.
Crossref
Crossref
M. E. Alnaeb, F. Youssef, D. P. MikhailidisG. Hamilton. (2016) Short-term Lipid-Lowering Treatment with Atorvastatin Improves Renal Function But Not Renal Blood Flow Indices in Patients with Peripheral Arterial Disease. Angiology 57:1, pages 65-71.
Crossref
Crossref
Stella S. Daskalopoulou & Dimitri P. Mikhailidis. 2006. Vascular Surgery. Vascular Surgery
133
140
.
Kosmas I. ParaskevasStella S. Daskalopoulou, Marios E. Daskalopoulos & Christos D. Liapis. (2016) Secondary Prevention of Ischemic Cerebrovascular Disease. What Is the Evidence?. Angiology 56:5, pages 539-552.
Crossref
Crossref
Joshua F. Baker, Eswar Krishnan, Lan Chen & H. Ralph Schumacher. (2005) Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?. The American Journal of Medicine 118:8, pages 816-826.
Crossref
Crossref
Stella S. Daskalopoulou, Vasilios G. Athyros, George Hamilton & Dimitri P. Mikhailidis. (2016) Lipid-Lowering Therapy in Patients with Peripheral Arterial Disease. Journal of Cardiovascular Pharmacology and Therapeutics 10:2, pages 145-147.
Crossref
Crossref
Nikolaos P. KadoglouStella S. Daskalopoulou, Despina Perrea & Christos D. Liapis. (2016) Matrix Metalloproteinases and Diabetic Vascular Complications. Angiology 56:2, pages 173-189.
Crossref
Crossref
S. S. Daskalopoulou, D. P. Mikhailidis & M. Elisaf. (2016) Prevention and Treatment of the Metabolic Syndrome. Angiology 55:6, pages 589-612.
Crossref
Crossref
Haralampos J Milionis, Vasilios G Athyros, Moses Elisaf & Dimitri P Mikhailidis. (2016) Structured care with atorvastatin in patients with type 2 diabetes mellitus and coronary heart disease. The British Journal of Diabetes & Vascular Disease 4:2, pages 94-97.
Crossref
Crossref